Expanded criteria for hepatocellular carcinoma after liver transplantation: A 20-year evolution

Hepato-Gastroenterology

Volumn 60, Issue 128, 2013, Pages 2039-2041

  Lai, Q ^a   Nudo, F ^a   Mennini, G ^a   Spoletini, G ^a   Morabito, V ^a   Levi Sandri, G B ^a   Melandro, F ^a   Guglielmo, N ^a   Berloco, P B ^a   Rossi, M ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Bridge therapy; Milan criteria; Recurrence; UCSF criteria

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; COHORT ANALYSIS; DISEASE FREE SURVIVAL; EVOLUTION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893642732     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11371     Document Type: Article

References (7)

1. Iwatsuki S, Starzl TE, Sheahan DG, et al.: Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214:221-228.
2. Mazzaferro V, Regalia E, Doci R, et al.: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699. (Pubitemid 26079803)
3. Yao FY, Kerlan RK, Hirose R, et al.: Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatol 2008; 48:819-827.
4. Yao FY, Ferrell L, Bass NM, et al.: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatol 2001; 33:1394-1403. (Pubitemid 32496976)
5. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, et al.: Impact of UCSF criteria according to pre- and post-OLT tumor parameters: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006; 12:1761-1769. (Pubitemid 44911801)
6. Bruix J, Sherman M, Llovet JM, et al.: Clinical management on hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001; 35:421-430. (Pubitemid 32844200)
7. Lai Q, Merli M, Ginanni Corradini S, et al.: Predictive factors of recurrence of hepatocellular carcinoma after liver transplantation: a multivariate analysis. Transplant Proc 2009; 41:1306-1309.